Advertisement

Reactions Weekly

, Volume 1696, Issue 1, pp 69–69 | Cite as

Brentuximab-vedotin

Pulmonary toxicity: case report
Case report
  • 26 Downloads

Reference

  1. Rauf MS, et al. Brentuximab vedotin for relapsed or refractory Hodgkin Lymphoma, Single center experience King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia. Bone Marrow Transplantation 52 (Suppl. 1): 331-332 (plus poster) abstr. B296, 2017 [abstract] - SaudiArabiaGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations